115 related articles for article (PubMed ID: 17896835)
1. Cutting-edge apoptosis-based therapeutics: a panacea for cancer?
Fischer U; Janssen K; Schulze-Osthoff K
BioDrugs; 2007; 21(5):273-97. PubMed ID: 17896835
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-based therapies and drug targets.
Fischer U; Schulze-Osthoff K
Cell Death Differ; 2005 Aug; 12 Suppl 1():942-61. PubMed ID: 15665817
[TBL] [Abstract][Full Text] [Related]
3. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
[TBL] [Abstract][Full Text] [Related]
4. The TRAIL of oncogenes to apoptosis.
Oikonomou E; Pintzas A
Biofactors; 2013; 39(4):343-54. PubMed ID: 23813857
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
[TBL] [Abstract][Full Text] [Related]
6. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).
Ashkenazi A; Holland P; Eckhardt SG
J Clin Oncol; 2008 Jul; 26(21):3621-30. PubMed ID: 18640940
[TBL] [Abstract][Full Text] [Related]
7. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
8. New approaches and therapeutics targeting apoptosis in disease.
Fischer U; Schulze-Osthoff K
Pharmacol Rev; 2005 Jun; 57(2):187-215. PubMed ID: 15914467
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis proteins as targets for anticancer therapy.
Fulda S
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
11. A time to kill: targeting apoptosis in cancer.
Koff JL; Ramachandiran S; Bernal-Mizrachi L
Int J Mol Sci; 2015 Jan; 16(2):2942-55. PubMed ID: 25636036
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.
Conticello C; Adamo L; Giuffrida R; Vicari L; Zeuner A; Eramo A; Anastasi G; Memeo L; Giuffrida D; Iannolo G; Gulisano M; De Maria R
J Clin Endocrinol Metab; 2007 May; 92(5):1938-42. PubMed ID: 17327374
[TBL] [Abstract][Full Text] [Related]
13. Is TRAIL the holy grail of cancer therapy?
Newsom-Davis T; Prieske S; Walczak H
Apoptosis; 2009 Apr; 14(4):607-23. PubMed ID: 19194800
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
16. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
17. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances for research on anti-tumor effects of TNF-related apoptosis-inducing ligand].
Yao GH; Hou YY
Wei Sheng Yan Jiu; 2006 Jan; 35(1):115-7. PubMed ID: 16598953
[TBL] [Abstract][Full Text] [Related]
19. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
20. Regulation of apoptosis proteins in cancer cells by ubiquitin.
Zhang HG; Wang J; Yang X; Hsu HC; Mountz JD
Oncogene; 2004 Mar; 23(11):2009-15. PubMed ID: 15021888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]